Below are the most recent publications written about "Immunotherapy, Adoptive" by people in Profiles.
-
Mailankody S, Mitra S, Herrera K, Ziccheddu B, Cadzin B, Eren OC, Farzana T, Ullah T, Landa J, Derkach A, Chaudhari J, McAvoy DP, Hosszu K, Shah GL, Landau H, Maura F, Dogan A, Giralt S, Wang X, Sadelain M, Smith EL, Brentjens RJ, Leslie C, Usmani SZ, Perica K. Concurrent administration of BCMA and GPRC5D CAR T cells for advanced multiple myeloma. Blood. 2026 Oct 22; 148(17):2121-2131.
-
Mian H, Faisal MS, Chen T, Brazauskas R, Oloyede T, Ahmed N, Afrough A, Anderson LD, Banerjee R, Berdeja J, Bidikian A, Devos J, Dhakal B, Dias A, Dima D, Efebera YA, Gowda L, Hansen DK, Hashmi H, Landau HJ, Lekakis L, Mirza AS, Narra R, Patel K, Rosko AE, Schroeder M, Sidana S, Usmani S, Pasquini MC, Nishihori T, Akhtar OS, Mohan M. Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis. Cancer. 2026 Oct 01; 132(19):e70614.
-
Herrera K, Mitra S, Sun Y, Lucero K, Singh KA, Chen K, Takizawa M, Shah GL, Giralt S, Park JH, Usmani SZ, Chaligne R, de Stanchina E, Mailankody S, Leslie CS, Perica K. The EF1? promoter of cilta-cel drives a highly effective GZMK+ transcriptional program. Nat Commun. 2026 09 19; 17(1).
-
Albach FN, Rehm MC, Hütter-Krönke ML, Le TH, Giezen JM, Torgutalp M, Sattler A, Minopoulou I, Biesen R, Wiebe E, Casteleyn V, Witte T, Furth C, Zernicke J, Nuesch Germano M, Verhagen J, Wilhelm A, Dzamukova M, Engel K, Schallenberg S, Kannt A, Ziegler N, Fehringer M, Schneider U, Unterwalder N, Beling M, Pfeil A, Phithak E, Krusche M, Penack O, Alexander T, Stenzel W, Wuhrer M, Movassaghi K, Dörner T, Latz E, Vogl T, Busse A, Schett G, Scherer HU, Toes REM, Kleyer A, Keller U, Bullinger L, Simon D, Krönke G. CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial. Nat Med. 2026 Oct; 32(10):3862-3873.
-
Jurgens EM, Mitra S, Herrera K, Nemirovsky D, Bready B, Derkach A, Hosszu K, McAvoy D, Firestone RS, Rajeeve S, Lesokhin AM, Korde N, Tan CR, Hashmi H, Hassoun H, Maclachlan K, Shah UA, Hultcrantz M, Merz M, Maura F, Giralt SA, Shah GL, Landau HJ, Scordo M, Kotchetkov IS, Santomasso BD, Park J, Leslie CS, Usmani SZ, Perica K, Mailankody S. Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma. Sci Transl Med. 2026 Jul 29; 18(860):eaed0039.
-
Pandey T, Samat D, Dahiya S, Patel SA. Multi-antigen chimeric antigen receptor-T cell therapy for relapsed/refractory B cell lymphomas. Front Immunol. 2026; 17:1900443.
-
Sotelo-Alva MI, Beyar-Katz O, Yan J, Escribano-Serrat S, Boardman A, Geva M, Gomez-Llobell M, Halloun J, Khatib H, Hultcrantz M, Lue J, Mailankody S, Papanicolaou G, Palomba L, Park JH, Rejeski K, Sanz J, Scordo M, Seo SK, Shah G, Shi K, Shibli N, Usmani S, Nishimura N, Shahid Z, Perales MA, Shouval R, Kamboj M, Einarsdottir S. Respiratory Syncytial Virus After Chimeric Antigen Receptor T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort. Clin Infect Dis. 2026 04 30; 82(4):618-621.
-
Hansen DK, Dima D, Mian H, Devos J, Brazauskas R, Oloyede T, Afrough A, Ahmed N, Anderson LD, Banerjee R, Berdeja JG, Bidikian A, Dhakal B, Dias A, Efebera Y, Faisal MS, Gowda L, Hashmi H, Mirza AS, Mohan M, Narra R, Rosko AE, Schroeder M, Nishihori T, Landau H, Usmani S, Pasquini MC, Akhtar OS, Sidana S, Patel KK. Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study. Blood Cancer J. 2026 04 14; 16(1).
-
Hashmi H, Sebastian T, Rajeeve S, Farzana T, Firestone RS, Jurgens EM, Miller KC, Maura F, Lesokhin AM, Tan CR, Shah GL, Korde N, Landau HJ, Merz M, Scordo M, Hassoun H, Maclachlan KH, Shah UA, Hultcrantz ML, Derkach A, Nemirovsky D, Giralt S, Mailankody S, Usmani SZ. Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma. Blood Cancer J. 2026 04 12; 16(1).
-
Koumpouras F, Caricchio R. Cellular therapies for rheumatic disease. Curr Opin Rheumatol. 2026 May 01; 38(3):155-162.